Ellex Medical Lasers Limited (ELX):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Ellex Medical Lasers Limited (ELX) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C12148
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:41
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Ellex Medical Lasers Limited (Ellex) is a medical technology company that develops, manufactures, sells and distributes medical equipment for use in ophthalmic procedures. The company also offers a range of third-party medical devices and technologies. Ellex’s product portfolio includes laser therapy equipment, intraocular lenses (IOLs), photocoagulators, and ultrasound systems for the diagnosis and treatment of cataract, glaucoma and retinal diseases. It also offers retinal rejuvenation therapy, and Ellex 2RT for the treatment of diabetic retinopathy and age-related macular degeneration (AMD). Ellex sells its products and provides services directly to ophthalmic surgeons and to others, through a network of distribution partners. The company has operations in Europe, Asia-Pacific and the Americas. Ellex is headquartered in Adelaide, Australia.

Ellex Medical Lasers Limited (ELX) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Ellex Medical Lasers Limited, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Ellex Medical Lasers Limited, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Ellex Medical Lasers Limited, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Ellex Medical Lasers Limited, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Ellex Medical Lasers Limited, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Ellex Medical Lasers Limited, Medical Equipment, Deal Details 10
Asset Purchase 10
Ellex Medical Lasers Completes Acquisition Of Canaloplasty Business Of iScience Interventional For US$1.5 Million 10
Equity Offering 12
Ellex Medical Raises USD9.3 Million in Second Tranche Private Placement of Shares 12
Ellex Medical Raises USD8.1 Million in First Tranche Private Placement of Shares 14
Ellex Medical Raises USD1.5 Million in Private Placement of Shares 16
Ellex Medical to Raise USD3.8 Million in Rights Offering of Shares 17
Ellex Medical Lasers Completes Private Placement Of Shares For US$2.7 Million 19
Ellex Medical Lasers Completes Private Placement Of Shares For US$3.1 Million 20
Ellex Medical Lasers Limited – Key Competitors 21
Ellex Medical Lasers Limited – Key Employees 22
Ellex Medical Lasers Limited – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 25
Strategy And Business Planning 25
Sep 01, 2017: Ellex iTrack undertakes second stage production facility expansion 25
Financial Announcements 26
Aug 30, 2018: Ellex reports full year FY18 audited results 26
Feb 27, 2018: Ellex Medical Lasers: Release of Financial Results for Half-Year ended 31 December 2017 28
Aug 25, 2017: Ellex Reports Full Year FY17 Audited Results 29
Jul 28, 2017: Ellex Medical Lasers: Trading Update Earnings 30
Feb 27, 2017: Ellex Medical Lasers: Financial Report for Half-Year Ended 31 December 2016 32
Feb 02, 2017: Ellex Trading Update for the Six Months Ended 31 December 2016 33
Corporate Communications 35
Oct 18, 2018: Ellex names Dr David Lubeck as Chief Medical Officer 35
Jul 02, 2018: Ellex Medical Lasers Appoints Mike Southard And Mr. Mike Mangano As Directors 36
Other Significant Developments 37
Feb 05, 2018: Ellex: Trading Update for Half-Year Ended 31 December 2017 37
Jul 06, 2017: Ellex Medical Lasers: Trading Update for the Year Ended 30 June 2017 38
Jun 22, 2017: Ellex iTrack Sales and Marketing Activities 40
Appendix 41
Methodology 41
About GlobalData 41
Contact Us 41
Disclaimer 41

List of Tables
Ellex Medical Lasers Limited, Medical Equipment, Key Facts, 2018 2
Ellex Medical Lasers Limited, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Ellex Medical Lasers Limited, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Ellex Medical Lasers Limited, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Ellex Medical Lasers Limited, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Ellex Medical Lasers Limited, Deals By Market, 2012 to YTD 2018 8
Ellex Medical Lasers Limited, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Ellex Medical Lasers Completes Acquisition Of Canaloplasty Business Of iScience Interventional For US$1.5 Million 10
Ellex Medical Raises USD9.3 Million in Second Tranche Private Placement of Shares 12
Ellex Medical Raises USD8.1 Million in First Tranche Private Placement of Shares 14
Ellex Medical Raises USD1.5 Million in Private Placement of Shares 16
Ellex Medical to Raise USD3.8 Million in Rights Offering of Shares 17
Ellex Medical Lasers Completes Private Placement Of Shares For US$2.7 Million 19
Ellex Medical Lasers Completes Private Placement Of Shares For US$3.1 Million 20
Ellex Medical Lasers Limited, Key Competitors 21
Ellex Medical Lasers Limited, Key Employees 22
Ellex Medical Lasers Limited, Other Locations 23
Ellex Medical Lasers Limited, Subsidiaries 23

List of Figures
Ellex Medical Lasers Limited, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Ellex Medical Lasers Limited, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Ellex Medical Lasers Limited, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Ellex Medical Lasers Limited, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Ellex Medical Lasers Limited, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Ellex Medical Lasers Limited, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Ellex Medical Lasers Limited, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Ellex Medical Lasers Limited, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Ellex Medical Lasers Limited (ELX):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Murree Brewery Co. Ltd.:戦略・SWOT・企業財務分析
    Murree Brewery Co. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Murree Brewery Co. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Intrum Justitia AB:企業のM&A・事業提携・投資動向
    Intrum Justitia AB - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Intrum Justitia AB Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • TOLMAR Inc-製薬・医療分野:企業M&A・提携分析
    Summary TOLMAR Inc (TOLMAR), a subsidiary of Tolmar Holding Inc is a developer, manufacturer and distributor of pharmaceutical products. The company provides generic dermatology products such as creams, gels, ointments and solutions. It also provides levetiracetam oral solutions including antiepilep …
  • MGM Resorts International:企業の戦略・SWOT・財務情報
    MGM Resorts International - Strategy, SWOT and Corporate Finance Report Summary MGM Resorts International - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Husky Energy Inc. (HSE):企業の財務・戦略的SWOT分析
    Husky Energy Inc. (HSE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Versantis AG-製薬・医療分野:企業M&A・提携分析
    Summary Versantis AG (Versantis), is a preclinical stage pharmaceutical company which offers new medicines and diagnostics for treating liver diseases. It’s lead pipeline product VS-01, capable of removing toxic agents from the organism and save patients from prescription and illicit drug overdoses. …
  • Intertek Group Plc (ITRK):石油・ガス:M&Aディール及び事業提携情報
    Summary Intertek Group Plc (Intertek) is a provider of quality and safety solutions to various businesses across the globe. It offers services such as testing, inspection, certification, auditing, advisory services, quality assurance, consulting, sourcing, hazardous substance testing, analytical ass …
  • DKSH Holding Ltd. (DKSH):企業の財務・戦略的SWOT分析
    DKSH Holding Ltd. (DKSH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Chugoku Marine Paints, Ltd. (4617):企業の財務・戦略的SWOT分析
    Chugoku Marine Paints, Ltd. (4617) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Editas Medicine Inc (EDIT):企業の財務・戦略的SWOT分析
    Editas Medicine Inc (EDIT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Lunaphore Technologies SA:医療機器:M&Aディール及び事業提携情報
    Summary Lunaphore Technologies SA (Lunaphore) is a medical device company that develops tissue processing solutions for inmmunohistochemistry. The company builds tumor analysis and classification platforms based on a microfluidic technologies. It offers FFeX, a fast fluidic exchange technology that …
  • Nidec Corporation:企業の戦略・SWOT・財務情報
    Nidec Corporation - Strategy, SWOT and Corporate Finance Report Summary Nidec Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • NG Biotech:企業の製品パイプライン分析
    Summary NG Biotech (NG Biotech) is a biotech company that develops and manufactures novel in vitro diagnostic tools for therapy monitoring. The company’s products include whole blood pregnancy tests, M-health malaria tests, NG Test readers, antibiotic resistance tests, and OTC tests. It also develop …
  • Florida Keys Electric Cooperative Association, Inc.:発電所・企業SWOT分析
    Florida Keys Electric Cooperative Association, Inc. - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analys …
  • ProteinSimple-医療機器分野:企業M&A・提携分析
    Summary ProteinSimple, formerly Cell Biosciences Inc, a subsidiary of Bio Techne Corp, is a medical device company that offers protein analysis solutions. The company offers products such as simple plex systems, simple western systems, micro-flow imaging systems, cIEF and CE-SDS; gel documentation s …
  • British Columbia Investment Management Corp:企業の戦略的SWOT分析
    British Columbia Investment Management Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors a …
  • Depuy Synthes Companies:企業の戦略・SWOT・財務分析
    Depuy Synthes Companies - Strategy, SWOT and Corporate Finance Report Summary Depuy Synthes Companies - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Biohit Oyj (BIOBV):医療機器:M&Aディール及び事業提携情報
    Summary Biohit Oyj (Biohit) is a biotechnology company that offers research and early diagnosis processing products. The company’s products comprise acetaldehyde binding products, diagnostic tests, dysbiosis test, microplate readers and washers, monoclonal antibodies, and pipettes. It targets therap …
  • SMART Global Holdings, Inc. (SGH):企業の財務・戦略的SWOT分析
    SMART Global Holdings, Inc. (SGH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Sunrise Medical (US) LLC:企業の戦略的SWOT分析
    Sunrise Medical (US) LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆